SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Doctors: TPP Would Trample Access to Medicines
Médecins Sans Frontières warns that lives hang in balance of secret pact
Jul 08, 2014
International humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) warned Monday that the highly secretive Trans-Pacific Partnership will further erode access to life saving medicines in all countries involved in the deal, hitting poor and vulnerable people the hardest.
The organization joins a crescendo of voices warning of the potentially deadly effects of the mammoth pact as another round of closed-door negotiations commences in Ottawa, Canada.
"Every TPP government is struggling to contain rising health costs, so it's beyond reason why provisions designed to delay the introduction of low-cost generic medicines would be allowed to make it into the final TPP agreement," said Stephen Cornish, executive director of MSF Canada, in a statement.
The "free trade" deal is currently under negotiation between Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, United States, and Vietnam--which combined comprise approximately 40 percent of the world's GDP.
The U.S. has been aggressively pushing proposals to expand and reinforce pharmaceutical corporations' monopolies on life-saving drugs and restrict the abilities of governments to protect access to lower-cost generic medicines.
The pact is slated to include NAFTA's infamous corporate tribunals, which allow corporations to sue governments in secret courts, circumventing national legal systems. Using this provision in NAFTA, pharmaceutical giant Eli Lilly sued the Canadian government in 2012 on charges that Canada "favors" generic medicines. The secret tribunal ruling has the potential to change Canadian drug laws.
MSF declared in its statement, "To see the harmful effects of the stringent intellectual property rules that the U.S. seeks to impose on TPP countries, we need only look to the U.S. market, where medicine prices have tripled since 1987, outpacing consumer prices, which have only doubled."
"Higher medicine prices cost lives in countries at every level of economic development, and the TPP regulations in question should be rejected outright," said Judit Rius, U.S. manager and legal policy adviser of the MSF Access Campaign.
_____________________
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Sarah Lazare
Sarah Lazare is the editor of Workday Magazine and a contributing editor for In These Times. She is a former Staff Writer at Common Dreams. She comes from a background in independent journalism for publications including The Intercept, The Nation, and Tom Dispatch.
International humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) warned Monday that the highly secretive Trans-Pacific Partnership will further erode access to life saving medicines in all countries involved in the deal, hitting poor and vulnerable people the hardest.
The organization joins a crescendo of voices warning of the potentially deadly effects of the mammoth pact as another round of closed-door negotiations commences in Ottawa, Canada.
"Every TPP government is struggling to contain rising health costs, so it's beyond reason why provisions designed to delay the introduction of low-cost generic medicines would be allowed to make it into the final TPP agreement," said Stephen Cornish, executive director of MSF Canada, in a statement.
The "free trade" deal is currently under negotiation between Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, United States, and Vietnam--which combined comprise approximately 40 percent of the world's GDP.
The U.S. has been aggressively pushing proposals to expand and reinforce pharmaceutical corporations' monopolies on life-saving drugs and restrict the abilities of governments to protect access to lower-cost generic medicines.
The pact is slated to include NAFTA's infamous corporate tribunals, which allow corporations to sue governments in secret courts, circumventing national legal systems. Using this provision in NAFTA, pharmaceutical giant Eli Lilly sued the Canadian government in 2012 on charges that Canada "favors" generic medicines. The secret tribunal ruling has the potential to change Canadian drug laws.
MSF declared in its statement, "To see the harmful effects of the stringent intellectual property rules that the U.S. seeks to impose on TPP countries, we need only look to the U.S. market, where medicine prices have tripled since 1987, outpacing consumer prices, which have only doubled."
"Higher medicine prices cost lives in countries at every level of economic development, and the TPP regulations in question should be rejected outright," said Judit Rius, U.S. manager and legal policy adviser of the MSF Access Campaign.
_____________________
Sarah Lazare
Sarah Lazare is the editor of Workday Magazine and a contributing editor for In These Times. She is a former Staff Writer at Common Dreams. She comes from a background in independent journalism for publications including The Intercept, The Nation, and Tom Dispatch.
International humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) warned Monday that the highly secretive Trans-Pacific Partnership will further erode access to life saving medicines in all countries involved in the deal, hitting poor and vulnerable people the hardest.
The organization joins a crescendo of voices warning of the potentially deadly effects of the mammoth pact as another round of closed-door negotiations commences in Ottawa, Canada.
"Every TPP government is struggling to contain rising health costs, so it's beyond reason why provisions designed to delay the introduction of low-cost generic medicines would be allowed to make it into the final TPP agreement," said Stephen Cornish, executive director of MSF Canada, in a statement.
The "free trade" deal is currently under negotiation between Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, United States, and Vietnam--which combined comprise approximately 40 percent of the world's GDP.
The U.S. has been aggressively pushing proposals to expand and reinforce pharmaceutical corporations' monopolies on life-saving drugs and restrict the abilities of governments to protect access to lower-cost generic medicines.
The pact is slated to include NAFTA's infamous corporate tribunals, which allow corporations to sue governments in secret courts, circumventing national legal systems. Using this provision in NAFTA, pharmaceutical giant Eli Lilly sued the Canadian government in 2012 on charges that Canada "favors" generic medicines. The secret tribunal ruling has the potential to change Canadian drug laws.
MSF declared in its statement, "To see the harmful effects of the stringent intellectual property rules that the U.S. seeks to impose on TPP countries, we need only look to the U.S. market, where medicine prices have tripled since 1987, outpacing consumer prices, which have only doubled."
"Higher medicine prices cost lives in countries at every level of economic development, and the TPP regulations in question should be rejected outright," said Judit Rius, U.S. manager and legal policy adviser of the MSF Access Campaign.
_____________________
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.
To inform. To inspire. To ignite change for the common good.
News & Opinion
Trending
Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit
Privacy Policy